nodes	percent_of_prediction	percent_of_DWPC	metapath
Octreotide—SSTR4—forebrain—attention deficit hyperactivity disorder	0.0364	0.0991	CbGeAlD
Octreotide—MPO—saliva—attention deficit hyperactivity disorder	0.0317	0.0862	CbGeAlD
Octreotide—SSTR1—forebrain—attention deficit hyperactivity disorder	0.0234	0.0639	CbGeAlD
Octreotide—SSTR2—forebrain—attention deficit hyperactivity disorder	0.0199	0.0543	CbGeAlD
Octreotide—SSTR4—nervous system—attention deficit hyperactivity disorder	0.0197	0.0538	CbGeAlD
Octreotide—SSTR4—central nervous system—attention deficit hyperactivity disorder	0.019	0.0518	CbGeAlD
Octreotide—SSTR3—nervous system—attention deficit hyperactivity disorder	0.0161	0.0439	CbGeAlD
Octreotide—SSTR5—cerebellum—attention deficit hyperactivity disorder	0.0158	0.043	CbGeAlD
Octreotide—SSTR3—central nervous system—attention deficit hyperactivity disorder	0.0155	0.0422	CbGeAlD
Octreotide—SSTR1—midbrain—attention deficit hyperactivity disorder	0.0155	0.0422	CbGeAlD
Octreotide—SSTR3—cerebellum—attention deficit hyperactivity disorder	0.0151	0.0413	CbGeAlD
Octreotide—SSTR4—brain—attention deficit hyperactivity disorder	0.0151	0.0411	CbGeAlD
Octreotide—SSTR1—nervous system—attention deficit hyperactivity disorder	0.0127	0.0347	CbGeAlD
Octreotide—SSTR3—brain—attention deficit hyperactivity disorder	0.0123	0.0335	CbGeAlD
Octreotide—SSTR1—central nervous system—attention deficit hyperactivity disorder	0.0123	0.0334	CbGeAlD
Octreotide—SSTR1—cerebellum—attention deficit hyperactivity disorder	0.012	0.0326	CbGeAlD
Octreotide—SSTR2—nervous system—attention deficit hyperactivity disorder	0.0108	0.0295	CbGeAlD
Octreotide—SSTR2—central nervous system—attention deficit hyperactivity disorder	0.0104	0.0284	CbGeAlD
Octreotide—SSTR2—cerebellum—attention deficit hyperactivity disorder	0.0102	0.0277	CbGeAlD
Octreotide—SSTR1—brain—attention deficit hyperactivity disorder	0.00973	0.0265	CbGeAlD
Octreotide—SSTR2—brain—attention deficit hyperactivity disorder	0.00827	0.0225	CbGeAlD
Octreotide—MPO—forebrain—attention deficit hyperactivity disorder	0.00755	0.0206	CbGeAlD
Octreotide—MPO—cardiovascular system—attention deficit hyperactivity disorder	0.00638	0.0174	CbGeAlD
Octreotide—MPO—nervous system—attention deficit hyperactivity disorder	0.0041	0.0112	CbGeAlD
Octreotide—MPO—central nervous system—attention deficit hyperactivity disorder	0.00394	0.0107	CbGeAlD
Octreotide—MPO—brain—attention deficit hyperactivity disorder	0.00313	0.00853	CbGeAlD
Octreotide—SSTR5—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00176	0.00278	CbGpPWpGaD
Octreotide—SSTR4—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00176	0.00278	CbGpPWpGaD
Octreotide—SSTR4—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00176	0.00278	CbGpPWpGaD
Octreotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00175	0.00276	CbGpPWpGaD
Octreotide—SSTR2—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.00175	0.00276	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00174	0.00275	CbGpPWpGaD
Octreotide—SSTR5—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00174	0.00275	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00174	0.00275	CbGpPWpGaD
Octreotide—SSTR5—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00174	0.00274	CbGpPWpGaD
Octreotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00173	0.00273	CbGpPWpGaD
Octreotide—SSTR2—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.00173	0.00273	CbGpPWpGaD
Octreotide—SSTR2—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.0017	0.00269	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.0017	0.00269	CbGpPWpGaD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.0017	0.00269	CbGpPWpGaD
Octreotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.0017	0.00268	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.0017	0.00268	CbGpPWpGaD
Octreotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00168	0.00265	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00167	0.00264	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00167	0.00264	CbGpPWpGaD
Octreotide—SSTR2—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00165	0.00261	CbGpPWpGaD
Octreotide—SSTR4—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00164	0.00259	CbGpPWpGaD
Octreotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00163	0.00257	CbGpPWpGaD
Octreotide—SSTR2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00162	0.00256	CbGpPWpGaD
Octreotide—SSTR5—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00162	0.00255	CbGpPWpGaD
Octreotide—SSTR2—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00161	0.00254	CbGpPWpGaD
Octreotide—SSTR2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.0016	0.00253	CbGpPWpGaD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00158	0.0025	CbGpPWpGaD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00157	0.00248	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.00156	0.00247	CbGpPWpGaD
Octreotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00156	0.00247	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00154	0.00243	CbGpPWpGaD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00153	0.00242	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00153	0.00242	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00152	0.00241	CbGpPWpGaD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00151	0.00238	CbGpPWpGaD
Octreotide—SSTR4—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00151	0.00238	CbGpPWpGaD
Octreotide—SSTR2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00149	0.00236	CbGpPWpGaD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00149	0.00235	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00148	0.00234	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00146	0.00231	CbGpPWpGaD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00146	0.00231	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00145	0.00229	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00142	0.00224	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00142	0.00224	CbGpPWpGaD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00141	0.00223	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00139	0.0022	CbGpPWpGaD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00139	0.00219	CbGpPWpGaD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00139	0.00219	CbGpPWpGaD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00137	0.00217	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00137	0.00217	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00137	0.00216	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00136	0.00215	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00136	0.00215	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00135	0.00213	CbGpPWpGaD
Octreotide—SSTR3—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00133	0.0021	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00133	0.0021	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00132	0.00208	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00132	0.00208	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.0013	0.00205	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.0013	0.00205	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00129	0.00204	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00129	0.00204	CbGpPWpGaD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00128	0.00202	CbGpPWpGaD
Octreotide—SSTR1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00128	0.00202	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00128	0.00202	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00126	0.002	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00124	0.00196	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00124	0.00195	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00123	0.00195	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00121	0.00191	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.0012	0.0019	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.0012	0.00189	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00119	0.00189	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00119	0.00188	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00118	0.00186	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00117	0.00184	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00116	0.00183	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00115	0.00181	CbGpPWpGaD
Octreotide—SSTR4—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00115	0.00181	CbGpPWpGaD
Octreotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00114	0.0018	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00114	0.0018	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00114	0.00179	CbGpPWpGaD
Octreotide—SSTR5—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00113	0.00179	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00113	0.00179	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00112	0.00177	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00112	0.00176	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00111	0.00176	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00111	0.00176	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.0011	0.00173	CbGpPWpGaD
Octreotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00109	0.00173	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00108	0.0017	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00106	0.00167	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00106	0.00167	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00105	0.00167	CbGpPWpGaD
Octreotide—SSTR2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00104	0.00165	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00104	0.00165	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00103	0.00163	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00103	0.00163	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00103	0.00162	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00102	0.00162	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00101	0.0016	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.00101	0.0016	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00101	0.00159	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00101	0.00159	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000993	0.00157	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000986	0.00156	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000986	0.00156	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000985	0.00156	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000973	0.00154	CbGpPWpGaD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00097	0.00153	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000959	0.00152	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000944	0.00149	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000929	0.00147	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000925	0.00146	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000913	0.00144	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00091	0.00144	CbGpPWpGaD
Octreotide—MPO—C-MYB transcription factor network—EP300—attention deficit hyperactivity disorder	0.000909	0.00144	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000906	0.00143	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000902	0.00142	CbGpPWpGaD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000895	0.00141	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000894	0.00141	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000869	0.00137	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000868	0.00137	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000861	0.00136	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000857	0.00135	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00084	0.00133	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000837	0.00132	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000833	0.00132	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000828	0.00131	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000825	0.0013	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.0008	0.00126	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000782	0.00124	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000778	0.00123	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000775	0.00122	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000773	0.00122	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00077	0.00122	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000767	0.00121	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000762	0.0012	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000762	0.0012	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00076	0.0012	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000752	0.00119	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00075	0.00118	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000748	0.00118	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000746	0.00118	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000743	0.00117	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000739	0.00117	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000732	0.00116	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000731	0.00115	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00073	0.00115	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000727	0.00115	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000721	0.00114	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000717	0.00113	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000711	0.00112	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000704	0.00111	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000702	0.00111	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000701	0.00111	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000697	0.0011	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000697	0.0011	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000692	0.00109	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000683	0.00108	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000682	0.00108	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000681	0.00108	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000676	0.00107	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000675	0.00107	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000672	0.00106	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000665	0.00105	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000663	0.00105	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000662	0.00105	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000659	0.00104	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000655	0.00104	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000648	0.00102	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000648	0.00102	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000648	0.00102	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00064	0.00101	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000637	0.00101	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000636	0.001	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000628	0.000992	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000618	0.000976	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000613	0.000969	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000611	0.000965	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00061	0.000964	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000609	0.000963	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000608	0.000961	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000599	0.000946	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000598	0.000945	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000598	0.000945	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000596	0.000942	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00059	0.000933	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000588	0.000929	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000588	0.000929	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000587	0.000927	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000581	0.000918	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00057	0.000901	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000567	0.000895	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000552	0.000873	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00055	0.000869	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000549	0.000867	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000543	0.000858	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000541	0.000855	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000539	0.000852	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000536	0.000847	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000533	0.000842	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000528	0.000835	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000507	0.0008	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.0005	0.000789	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000496	0.000784	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000491	0.000776	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000471	0.000744	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000462	0.00073	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000449	0.00071	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000446	0.000704	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000443	0.0007	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000429	0.000678	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000427	0.000675	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000417	0.00066	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000416	0.000657	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000415	0.000655	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000412	0.00065	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000409	0.000646	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000404	0.000638	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000399	0.00063	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000393	0.00062	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000392	0.000619	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000387	0.000611	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000385	0.000609	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000379	0.000599	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000376	0.000594	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000365	0.000577	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000362	0.000573	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000361	0.00057	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000354	0.000559	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00035	0.000553	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000348	0.000549	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000348	0.000549	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000343	0.000542	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000337	0.000532	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000326	0.000515	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000321	0.000507	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.00032	0.000505	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000317	0.0005	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000295	0.000466	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000263	0.000416	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000253	0.000399	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000224	0.000354	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000207	0.000327	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000184	0.000291	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.00014	0.00022	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000134	0.000211	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000119	0.000187	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000109	0.000173	CbGpPWpGaD
